Kathryn Babiarz

Client Coordinator

Kathryn Babiarz joined Melior in November of 2021 as the Client Coordinator. Prior to joining Melior, Kathryn graduated from the University of Kentucky with her master’s degree in Veterinary Science, as well as a graduate certificate in Technical and Professional Writing. Kathryn also attended the University of Delaware, where she received her bachelor’s degree in Animal Biosciences.

Throughout her academic career, Kathryn’s research was primarily equine focused. While attending the University of Delaware, her projects centered around nutrition with an equine gut microbiome focus. In 2019, Kathryn joined the equine musculoskeletal science lab, part of the Gluck Equine Research Center at the University of Kentucky. There, she studied the adaptation of equine proximal sesamoid bones to high-speed exercise in racing thoroughbreds through the use of advanced imaging modalities including computed tomography and micro-computed tomography.

Kathryn is excited to be working directly with the clients as the client coordinator for Melior, as well as learning about new projects, and opportunities. Learning about complex problems that need solving is one of her favorite parts of the scientific process.

In her free time, Kathryn enjoys volunteering at the local animal shelter, reading, and spending time with her family and friends.

We chose Melior Discovery because they were responsive and cost effective. We are staying with them as a chosen scientific partner because of their thoughtful scientific input to experimental design and attention to detail. Their expertise and flexibility allowed us to quickly adapt the study design and evaluate additional outcome measures to pursue unexpected activity.
Sridharan Rajamani, Ph.D., Senior Research Scientist
Gilead Sciences
I have been working with Melior on a number of projects over the course of a few years now. They have been a great partner throughout this time. The scientists whom I have worked with have been great problem-solvers and were customer focused.
Jay Lichter
Avalon Ventures
Melior provided State-of-the-art Preclinical Pharmacology Support for a period of nearly a year where a series of in vivo studies were completed on a weekly basis. The staff was extremely user-friendly and the operational processes were excellent. I can recommend Melior without reservation.
Richard DiMarchi, PhD
Cox Professor of Chemistry & Gill Chair in Biomolecular Sciences Indiana University, Department of Chemistry
Because Melior could do the orthotopic intracranial implants, we were able to do survival studies with brain tumor-bearing animals that were treated with our therapy, showing a beautiful survival with our agent versus control. Talk about something that gets your investors going! These beautiful survival curves with our agent versus control and visual photos are in all of our investor decks because… it's powerful.
Bruce Ruggeri, Ph.D.
Modifi Bio
Melior works in many therapeutic areas, like CNS, inflammatory disease, GI, cardiovascular, and oncology. I was very pleased that when it came to doing tumor studies, both subcutaneous and intracranial, they did them well. They reported on the studies on time and did the data analysis really well.
Bruce Ruggeri, Ph.D.
Modifi Bio
Their areas of expertise are extensive, and they are very experienced, responsive, and flexible in terms of how the study is run. Their pricing is reasonable, making them the best option for a young, not well-funded company like ours.
Maxine Gowen
Tamuro Bio
Melior’s team was very experienced and knowledgeable. They were always very open to suggestions and questions, spending a lot of time helping us feel comfortable with the study design. I would give them very high marks.
Maxine Gowen
Tamuro Bio
The most important factors in choosing to work with Melior were the fit between the tests they could run and our needs, as well as their tight budget and proximity. Melior was the best fit for our research goals.
Ira Spector
SFA Therapeutics